Skip to main content
Joaquin Duato, Chairman of the Board and Chief Executive Officer (photo)

A note from the CEO

At Johnson & Johnson, DEI is a business imperative. Our diverse, global workforce, and culture of belonging, accelerate innovation so that we can tackle the world’s toughest health challenges.

In a dynamic world, our strong foundation in DEI enables us to advance our business and meet the needs of all those who count on us.

Our annual We All Belong: DEI Impact Review brings together a collection of DEI best practices from across Johnson & Johnson, illustrated through data and stories from around the world.

Joaquin Duato, Chairman of the Board and Chief Executive Officer, engages with employees during a tour of a Johnson & Johnson research lab. (photo)
Joaquin Duato, Chairman and Chief Executive Officer, engages with employees during a tour of a Johnson & Johnson research lab
Joaquin Duato, Chairman of the Board and Chief Executive Officer, takes a photo with employees during a company event at J&J World Headquarters in New Brunswick, NJ. (photo)
Joaquin Duato, Chairman and Chief Executive Officer, takes a photo with employees during a company event at J&J World Headquarters in New Brunswick, NJ

I’m proud of what our teams accomplished in 2023. In response to our most recent Credo survey, 85% of employees agreed that “J&J provides an inclusive work environment where each employee is considered as an individual.” When our employees show up as their authentic selves and are empowered to advocate for themselves and their communities, our potential for success is even greater.

We believe in the power of equity to shape a better business environment and healthier world. Since 2020, Our Race to Health Equity has reached 4.5 million people of color in the United States (U.S.), through community-led programs to provide vital health services and information. In doing so, we are helping to close the racial health gap and advance more equitable access to healthcare.

We are also helping shape the future of clinical trials by ensuring they are more diverse, inclusive and equitable. This helps us to better understand and meet the needs of the diverse communities we serve. In the U.S., we spent $3.9 billion with Tier 1 diverse and small business suppliers, and we continued to drive our supplier diversity program globally, with a presence in 20 countries.

Our DEI impact would not be possible without the shared commitment of Johnson & Johnson colleagues. Together we are shaping a future where equitable opportunities and good health are within reach for the people who count on us every day.

Joaquin Duato's signature (signature)
Joaquin Duato Chairman and Chief Executive Officer